Filed a patent for "duplexbodies" on Mon, January 29, 2024
Filed a patent for "bispecific egfr/cd16 antigen-binding protein" on Thu, June 22, 2023
Filed a patent for "trispecific binders" on Thu, November 16, 2023
Filed a patent for "method for the production of bispecific fcyriii x cd30 antibody construct" on Thu, October 27, 2022
